These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9123372)

  • 21. Genetic analysis of the anti-leukemic effect of mixed allogeneic bone marrow transplantation.
    Sykes M; Sachs DH
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3022-4. PubMed ID: 2650417
    [No Abstract]   [Full Text] [Related]  

  • 22. MLR and skin graft studies in xenogeneic iso-, allo-, and xeno-combinations using HLA-DP and -DQ transgenic mice.
    Hagihara M; Shimura T; Tsuchida F; Takebe K; Munkhbat B; Tsuji K
    Transplant Proc; 1994 Apr; 26(2):967-8. PubMed ID: 8171718
    [No Abstract]   [Full Text] [Related]  

  • 23. CD8+ cytotoxic T lymphocytes are involved in inducing medial cell dropout via apoptosis in mouse aortic allografts.
    O'Neill JL; Lee TD; Hirsch GM
    Transplant Proc; 1999; 31(1-2):865-6. PubMed ID: 10083377
    [No Abstract]   [Full Text] [Related]  

  • 24. MHC-coded unique alloantigens and antitumor immunity.
    Martin WJ
    Transplant Proc; 1981 Dec; 13(4):1837-40. PubMed ID: 7036480
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of H-2Db antigens implies haplotype differences in the number of H-2 molecules expressed.
    Melino MR; Nichols EA; Strausser HR; Hansen TH
    J Immunol; 1982 Jul; 129(1):222-6. PubMed ID: 6177750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo immune response to allogeneic hepatocytes.
    Bumgardner GL; Li J; Heininger MB; Xia D; Parker-Thornberg J; Orosz CG; Ferguson RM
    Transplant Proc; 1997 Jun; 29(4):2059-60. PubMed ID: 9193525
    [No Abstract]   [Full Text] [Related]  

  • 27. NK cell tolerance in mixed allogeneic chimeras.
    Zhao Y; Ohdan H; Manilay JO; Sykes M
    J Immunol; 2003 Jun; 170(11):5398-405. PubMed ID: 12759414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic characterization of products of cloned H-2b genes.
    Oudshoorn-Snoek M; Demant P; Mellor AL; Flavell RA
    Transplant Proc; 1983 Dec; 15(4):2027-32. PubMed ID: 6200973
    [No Abstract]   [Full Text] [Related]  

  • 29. Xenogeneic (rat to mouse) skin tolerance induced by monoclonal antibodies, xenogeneic cells, and cyclophosphamide.
    Umesue M; Mayumi H; Nishimura Y; Kong YY; Omoto K; Murakami Y; Nomoto K; Nomoto K
    Transplant Proc; 1995 Feb; 27(1):315-6. PubMed ID: 7879018
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of immune response to nerve and skin allografts.
    Trumble T; Gunlikson R; Parvin D
    J Reconstr Microsurg; 1993 Sep; 9(5):367-72. PubMed ID: 8301635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Fas/FasL apoptotic pathway in the development of chronic rejection.
    Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):1397-8. PubMed ID: 10083618
    [No Abstract]   [Full Text] [Related]  

  • 32. CD8+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens.
    Borenstein SH; Graham J; Zhang XL; Chamberlain JW
    J Immunol; 2000 Sep; 165(5):2341-53. PubMed ID: 10946256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice.
    Newell KA; He G; Hart J; Thistlethwaite JR
    Transplantation; 1997 Oct; 64(7):959-65. PubMed ID: 9381541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
    Parmiani G; Ballinari D; Sensi ML
    J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of immune tolerance across major histocompatibility complex barrier by transfusion of ultraviolet B-irradiated immature dendritic cells.
    Xia CQ; Kao KJ
    Transfusion; 2005 Feb; 45(2):181-8. PubMed ID: 15660825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The major histocompatibility complex haplotype affects T-cell recognition of mycobacterial antigens but not resistance to Mycobacterium tuberculosis in C3H mice.
    Kamath AB; Alt J; Debbabi H; Taylor C; Behar SM
    Infect Immun; 2004 Dec; 72(12):6790-8. PubMed ID: 15557599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of donor-specific tolerance using superagonistic CD28 antibody in rat renal allografts: regulatory T-cell expansion before engraftment may be important.
    Azuma H; Isaka Y; Nomi H; Inamoto T; Li XK; Hounig T; Takabatake Y; Ichimaru N; Ibuki N; Matsumoto K; Ubai T; Katsuoka Y; Takahara S
    Transplantation; 2010 Dec; 90(12):1328-35. PubMed ID: 21085062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
    Yang CP; Shittu E; Bell EB
    J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creation of chimeric hearts: a tool for testing the "passenger leukocyte" hypothesis.
    Eiref SD; Zhang W; Popma SH; Shah LJ; Moore JS; Rosengard BR
    Ann Thorac Surg; 1997 Sep; 64(3):628-33. PubMed ID: 9307449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.